Smart Inhalers Market

SKU: DM2515 | Last Updated On: Nov 26 2021 | No. of Pages: 180 | Available Formats

> Global Smart Inhalers Market Expected to reach a high CAGR of 41.1% By 2028: DataM Intelligence

Global Smart Inhalers Market is segmented By Type (Dry Powder Inhalers for the Smart Inhalers industry, Nasal Inhalers, Metered Dose Inhalers, Others), By Distribution Channel (Retail Pharmacies, Respiratory Care Centers, Hospital Pharmacies, Online Pharmacies), By Indication (Asthma, Chronic obstructive pulmonary disease (COPD), Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2021-2028

 

Market Overview

"Global Smart Inhalers Market" is expected to grow at a high CAGR of 41.1% during the forecasting period (2021-2028).

Smart inhalers are connected to multiple devices like mobiles, laptops, personal computers, etc., to monitor the patient’s information related to respiratory diseases. Smart inhalers can be connected through mobile induction,n which helps patients and healthcare providers monitor important information like medication schedules and dosage reminders. Inhalers use Bluetooth technology to detect, remind patients about the inhaler's use and medication timing to take care of patients. Smart inhalers can improve patients’ health to provide crucial for asthma and COPD information to keep their condition under control.

*Source: DataM Intelligence Analysis 

Market Dynamics:

The rising demand for smart inhalers drives the market due to the increasing prevalence of Asthma, COPD due to a surge in air pollution and smoking habits. According to the World Health Organization, in 2016, the estimated Asthma patients were over 339 million people globally, which most common disease among children and the geriatric population. This is a growing non-communicable disease owing to a surge in smoking habits and rising global air pollution. Smart inhalers can be connected via wireless technology through the mobile app & web platform, providing crucial for asthma collects data for doctors about each drug usage and information.

There is a rise in the launching and FDA clearance of new innovative technology implemented with patient monitoring and tracking Bluetooth enabled and app-based smart inhalers for Asthma and other respiratory diseases. On 23rd Jan 2020, the U.S. Food and Drugs Administration (FDA) has been cleared the smart inhaler cap from Cognita Labs, Known as CapMedic. The device can track patients' signals with a feedback mechanism and provide guidance to use inhalers correctly.

Segment Analysis

The global Smart inhalers market is segmented based on type, distribution channel, Indication, and region.

The global smart inhalers market is bifurcated into dry powder inhalers, nasal inhalers, metered-dose inhalers, and others in terms of Types. This metered dose inhalers segment has the highest share in 2019dueg to the increasing new technology-based launching of smart inhalers by prominent players like Merck, Novartis, Vectura Group, MannKind, Respirices, and Lupin. For instance, on 22nd Nov 2019, Lupin Company launched ADHERE as a smart device for metered-dose inhalers. This inhaler has the facility to connect with smartphone Indication via Bluetooth. It is a reusable smart device that tracks and sends reminders to the patient's daily medication usage and consumption patterns via smartphone through the "MyAdhero" app.

Similarly, dry powder inhalers and nasal inhalers are also growing faster due to a surge in the prevalence of respiratory diseases like Asthma, COPD, and many others across the globe with the population's surgeon. Dry powder inhalers are growing faster due to rising awareness of their advantages, like avoiding drug irritation and easy use.

**Source: DataM Intelligence Analysis

Depending upon indication, the global smart inhalers market is divided into Asthma

and chronic obstructive pulmonary disease (COPD).  Among this Asthma, the segment has the largest share due to the increasing prevalence of Asthma disease around the globe due to the surge in people's smoking habits.

Similarly, the chronic obstructive pulmonary disease (COPD) segment is also growing faster with a surge in the global COPD disease burden. According to the World Health Organization, in 2016, the Global Burden of COPD Disease was reported around more than 251 million cases, estimated that 3.17 million deaths were caused in 2015. This is primarily due to increasing air pollution worldwide,e which propels this segmental growth during the forecast period.

**Source: DataM Intelligence AnalysisThee global smart inhalers are segmented into retail pharmacies, respiratory care centers, hospital pharmacies, and online pharmacies depending on the distribution channels. Among these, the retail pharmacies segment had the highest market share in 2019. This growth is anticipated due to the rise in pharmacies' retail shops, increasing awareness about non-communication diseases like Asthma, COPD, etc.

Similarly, the online pharmacies segment has the highest market share due to increased healthcare online consulting trends with the surge in online sales through portals like Flipkart, Amazon, etc.

Furthermore, respiratory care centers and hospital pharmacies are also growing faster due to the increasing number of hospitals and respiratory centers worldwide, with the surge in the prevalence of respiratory diseases due to a surge in the global air pollution due to smoke. According to the World Health Organization, at least around 2 billion people were exposed to biomass fuel's toxic smoke in 2016.  

**Source: DataM Intelligence Analysis

Geographical Presentation

By region, the global Smart inhalers market is segmented into North America, South America, Europe, Asia-Pacific, Middle-East, and Africa. Among all of the regions, North America dominated the global smart inhalers market and expected to grow at the highest CAGR during the forecasted period due to the presence of advanced technology adoption and surge in prevalence of respiratory diseases followed by the European region. According to the American Lung Association, in 2016, there were around 3.5 million people. Ann estimated around 6.1 million children under 18 years were affected due to Asthma in North America, followed by Europe. This propels the smart inhalers demand in this region with increasing the number of leading players and the presence of advanced technology in this region.

The Asia-Pacific region is expected to have positive market growth due to the growing prevalence of Asthma due to surging in smoking habits and increasing air pollution. Forum of International Respiratory Societies in 2016, China has reported more than 300 million smokers with annual consumption of 2 trillion cigarettes, the highest tobacco consuming nation with a record of a single person dies every 30 seconds from tobacco use. Furthermore, increasing the adoption of advanced technology to prevent such respiratory disorders with smart inhalers with the surge in population will boost the market demand over the forecasted period.

**Source: DataM Intelligence Analysis

Competitive Analysis

The global smart inhalers market is highly competitive with the presence of several international and local markets. Product diversification, revenue generation, and opportunities intensify the market competition Merck, Novartis, Vectura Group, MannKind, Respironics, Orion Pharm, Hovione, AstraZeneca, OPKO Health Inc, Boehringer-Ingelheim, 3M, Teva, Sunovion Pharmaceuticals, Aristopharma, GlaxoSmithKline and Cohero Health LLC are the leading market players with significant market share.

Major players receive new technology sensors and app-based advanced smart inhalers for curing respiratory diseases in the healthcare industry. For instance, on 22nd Jan 2020, Teva Company had launched the world's first smart inhaler, which the FDA approved. Teva's smart inhaler, named ProAir Digihaler, was launched in the United States market through an sNDA Indication. The ProAir Digihaler has a sensor used in real-time tracking, monitoring the patients, and collecting the syncs data through a mobile app.

Companies are entering into collaborations, acquisitions, mergers, and licensing for increasing their market penetration. For instance, on 28th January 2020, Aptar Pharma, a leading drug delivery services and active packaging solutions Company has been partnered with Lupin Limited to launch India’s first smart connected device for metered-dose inhalers (MDI) called ADHERO.

Why Purchase the Report?

  • Visualize the composition of the global Smart inhalers market products in terms of Type, and Indication highlighting the critical commercial assets and players.
  • Identify commercial opportunities in the global Smart inhalers market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of global Smart inhalers market-level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

**The global Smart inhalers market report will provide access to approximately 53 market data tables, 44 figures, and 178 pages

Target Audience

  • Industry Investors/Investment Bankers
  • Suppliers/Buyers
  • Education & Research Institutes
  • Manufacturers
  • Research Professionals
  • Emerging Companies
  • Distributors

Trending Topics

Inhalation Therapy Nebulizer Market

Inhalable Drugs Market

 

Table of Contents

  1. Smart inhalers Market Methodology and Scope

    1. Research Methodology
    2. Research Objective and Scope of the Report
  2. Smart inhalers Market – Market Definition and Overview

  3. Smart inhalers Market – Executive Summary

    1. Market Snippet by Type
    2. Market Snippet by Distribution Channel
    3. Market Snippet by Indication
    4. Market Snippet by Region
  4. Smart inhalers Market Dynamics

    1. Market Impacting Factors
      1. Drivers
      2.  Restraints
      3. Impact Analysis
    2. Opportunity
  5. Smart inhalers Market – Industry Analysis

    1. Porter's Five Forces Analysis
    2. Supply Chain Analysis
    3. Regulatory Analysis
    4. Pricing Analysis
  6. Smart inhalers Market – By Type

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      2. Market Attractiveness Index, By Type
    2. Dry Powder Inhalers for the Smart Inhalers industry
      1. Introduction
      2. Market Size Analysis, US$ Mn, 2020-2028 and Y-o-Y Growth Analysis (%), 2021-2028
      3. Nasal Inhalers
      4. Metered Dose Inhalers
      5. Others

  7. Smart inhalers Market – By Distribution Channel

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
      2. Market Attractiveness Index, By Distribution Channel
    2. Retail Pharmacies
      1. Introduction
      2. Market Size Analysis, USD Mn, 2020-2028 and Y-o-Y Growth Analysis (%), 2021-2028
    3. Respiratory Care Centers
    4. Hospital Pharmacies
    5. Online Pharmacies
  8. Smart inhalers Market – By Indication

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
      2. Market Attractiveness Index, By Indication
    2. Asthma
      1. Introduction
      2. Market Size Analysis, USD Mn, 2020-2028 and Y-o-Y Growth Analysis (%), 2021-2028
    3. Chronic obstructive pulmonary disease (COPD)
    4. Others
  9. Smart inhalers Market - By Region

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
      2. Market Attractiveness Index, By Region
    2. North America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. The U.S.
        2. Canada
        3. Mexico
    3. Europe
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Germany
        2. The U.K.
        3. France
        4. Rest of Europe
    4. South America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Brazil
        2. Argentina
        3. Rest of South America
    5. Asia Pacific
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. China
        2. India
        3. Japan
        4. Australia
        5. Rest of Asia Pacific
    6. The Middle East and Africa
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
  10.  Smart inhalers Market Competitive Landscape

    1. Competitive Scenario
    2. Market Positioning/Share Analysis
    3. Mergers and Acquisitions Analysis
  11. Smart inhalers Market Company Profiles

    1. Merck
      1. Company Overview
      2. Form Portfolio and Description
      3. Key Highlights
      4. Financial Overview
    2. Novartis
    3. Vectura Group
    4. MannKind
    5. Respironics
    6. Orion Pharm
    7. Hovione
    8. AstraZeneca
    9. OPKO Health Inc
    10. Boehringer-Ingelheim
    11. 3M
    12. Teva
    13. Sunovion Pharmaceuticals
    14. Aristopharma
    15. GlaxoSmithKline
    16. Cohero Health LLC  (*List Is Not Exhaustive)
  12. Smart inhalers Market – Premium Insights

  13. Smart inhalers Market – DataM

    1. Appendix
    2. About Us and Services

Contact Us

List of Tables & Figures

List of Tables 

Table 1 Global Smart inhalers Market Value, By Type, 2020,2024 & 2028 ($ Million)

Table 2 Global Smart inhalers Market Value, By Indication, 2020,2024 & 2028 ($ Million)

Table 3 Global Smart inhalers Market Value, By Distribution Channel, 2020,2024 & 2028 ($ Million)

Table 4 Global Smart inhalers Market Value, By Region, 2020,2024 & 2028 ($ Million)

Table 5 Global Smart inhalers Market Value, By Type, 2020,2024 & 2028 ($ Million)

Table 6 Global Smart inhalers Market Value, By Type, 2017-2028 ($ Million)

Table 7 Global Smart inhalers Market Value, By Indication, 2020,2024 & 2028 ($ Million)

Table 8 Global Smart inhalers Market Value, By Indication, 2017-2028 ($ Million)

Table 9 Global Smart inhalers Market Value, By Distribution Channel, 2017-2028 ($ Million)

Table 10 Global Smart inhalers Market Value, By Region, 2017-2028 ($ Million)

Table 11 North America Smart inhalers Market Value, By Type, 2017-2028 ($ Million)

Table 12 North America Smart inhalers Market Value, By Indication, 2017-2028 ($ Million)

Table 13 North America Smart inhalers Market Value, By Distribution Channel, 2017-2028 ($ Million)

Table 14 North America Smart inhalers Market Value, By Country, 2017-2028 ($ Million)

Table 15 South America Smart inhalers Market Value, By Type, 2017-2028 ($ Million)

Table 16 South America Smart inhalers Market Value, By Indication, 2017-2028 ($ Million)

Table 17 South America Smart inhalers Market Value, By Distribution Channel, 2017-2028 ($ Million)

Table 18 South America Smart inhalers Market Value, By Country, 2017-2028 ($ Million)

Table 19 Europe Smart inhalers Market Value, By Type, 2017-2028 ($ Million)

Table 20 Europe Smart inhalers Market Value, By Indication, 2017-2028 ($ Million)

Table 21 Europe Smart inhalers Market Value, By Distribution Channel, 2017-2028 ($ Million)

Table 22 Europe Smart inhalers Market Value, By Country, 2017-2028 ($ Million)

Table 23 Asia-Pacific Smart inhalers Market Value, By Type, 2017-2028 ($ Million)

Table 24 Asia-Pacific Smart inhalers Market Value, By Indication, 2017-2028 ($ Million)

Table 25 Asia-Pacific Smart inhalers Market Value, By Distribution Channel, 2017-2028 ($ Million)

Table 26 Asia-Pacific Smart inhalers Market Value, By Country, 2017-2028 ($ Million)

Table 27 Middle East & Africa Smart inhalers Market Value, By Type, 2017-2028 ($ Million)

Table 28 Middle East & Africa Smart inhalers Market Value, By Indication, 2017-2028 ($ Million)

Table 29 Middle East & Africa Smart inhalers Market Value, By Distribution Channel, 2017-2028 ($ Million)

Table 30 Merck: Overview

Table 31 Merck: Product Portfolio

Table 32 Merck: Key Developments

Table 33 Novartis: Overview

Table 34 Novartis: Product Portfolio

Table 35 Novartis: Key Developments

Table 36 Vectura Group: Overview

Table 37 Vectura Group: Product Portfolio

Table 38 Vectura Group: Key Developments

Table 39 MannKind: Overview

Table 40 MannKind: Product Portfolio

Table 41 MannKind: Key Developments

Table 42 Respirices: Overview

Table 43 Respirices: Product Portfolio

Table 44 Respirices: Key Developments

Table 45 Orion Pharm: Overview

Table 46 Orion Pharm: Product Portfolio

Table 47 Orion Pharm: Key Developments

Table 48 Hovione: Overview

Table 49 Hovione: Product Portfolio

Table 50 Hovione: Key Developments

Table 51 AstraZeneca: Overview

Table 52 AstraZeneca: Product Portfolio

Table 53 AstraZeneca: Key Developments

Table 54 OPKO Health Inc: Overview

Table 55 OPKO Health Inc: Product Portfolio

Table 56 OPKO Health Inc: Key Developments

Table 57 Boehringer-Ingelheim: Overview

Table 58 Boehringer-Ingelheim: Product Portfolio

Table 59 Boehringer-Ingelheim: Key Developments

Table 59       3M: Overview

Table 60       3M: Product Portfolio

Table 61        Teva: Overview

Table 62        Teva: Product Portfolio

Table 63        Teva: Key Developments

Table 64       Sunovion Pharmaceuticals: Overview

Table 65       Sunovion Pharmaceuticals: Product Portfolio

Table 66       Sunovion Pharmaceuticals

Table 67       Aristopharma: Overview

Table 68       Aristopharma: Product Portfolio

Table 69      Aristopharma: Key Developments

Table 70     GlaxoSmithKline: Overview

Table 71     GlaxoSmithKline: Product Portfolio

Table 72     GlaxoSmithKline: Key Developments

Table 73      Cohero Health LLC: Overview

Table 74      Cohero Health LLC: Product Portfolio

Table 75    Cohero Health LLC: Key Developments

 

List of Figures

Table 1 Global Smart inhaler Market Share, By Type, 2018 & 2028 (%)

Table 2 Global Smart inhalers Market Share, By Indication, 2018 & 2028 (%)

Table 3 Global Smart inhalers Market Share, By Distribution Channel, 2018 & 2028 (%)

Table 4 Global Smart inhalers Market Share, By Region, 2018 & 2028 (%)

Table 5 Global Smart inhalers Market Value, 2017-2028 ($ Million)

Table 6 Global Smart inhalers Market Y-o-Y Growth, By Type, 2018-2028 (%)

Table 7 Dry Powder Inhalers: Global Smart inhalers Market Value, 2017-2028 ($ Million)

Table 8 Nasal Inhalers: Global Smart inhalers Market Value, 2017-2028 ($ Million)

Table 9 Metered Dose Inhalers: Global Smart inhalers Market Value, 2017-2028 ($ Million)

Table 10 Others: Global Smart inhalers Market Value, 2017-2028 ($ Million)

Table 11 Global Smart inhalers Market Y-o-Y Growth, By Indication, 2018-2028 (%)

Table 12 Asthma: Global Smart inhalers Market Value, 2017-2028 ($ Million)

Table 13 Chronic obstructive pulmonary disease (COPD): Global Smart inhalers Market Value, 2017-2028 ($ Million)

Table 14 Global Smart inhalers Market Y-o-Y Growth, By Distribution Channel, 2018-2028 (%)

Table 15 Retail Pharmacies: Global Smart inhalers Market Value, 2017-2028 ($ Million)

Table 16 Respiratory Care Centers: Global Smart inhalers Market Value, 2017-2028 ($ Million)

Table 17 Hospital Pharmacies: Global Smart inhalers Market Value, 2017-2028 ($ Million)

Table 18 Online Pharmacies: Global Smart inhalers Market Value, 2017-2028 ($ Million)

Table 19 Global Smart inhalers Market Y-o-Y Growth, By 0, 2018-2028 (%)

Table 20 Global Smart inhalers Market Y-o-Y Growth, By Region, 2018-2028 (%)

Table 21 North America Smart inhalers Market Value, 2017-2028 ($ Million)

Table 22 North America Smart inhalers Market Share, By Type, 2018 & 2028 (%)

Table 23 North America Smart inhalers Market Share, By Indication, 2018 & 2028 (%)

Table 24 North America Smart inhalers Market Share, By Distribution Channel, 2018 & 2028 (%)

Table 25 North America Smart inhalers Market Share, By Country, 2018 & 2028 (%)

Table 26 South America Smart inhalers Market Value, 2017-2028 ($ Million)

Table 27 South America Smart inhalers Market Share, By Type, 2018 & 2028 (%)

Table 28 South America Smart inhalers Market Share, By Indication, 2018 & 2028 (%)

Table 29 South America Smart inhalers Market Share, By Distribution Channel, 2018 & 2028 (%)

Table 30 South America Smart inhalers Market Share, By Country, 2018 & 2028 (%)

Table 31 Europe Smart inhalers Market Value, 2017-2028 ($ Million)

Table 32 Europe Smart inhalers Market Share, By Type, 2018 & 2028 (%)

Table 33 Europe Smart inhalers Market Share, By Indication, 2018 & 2028 (%)

Table 34 Europe Smart inhalers Market Share, By Distribution Channel, 2018 & 2028 (%)

Table 35 Europe Smart inhalers Market Share, By Country, 2018 & 2028 (%)

Table 36 Asia-Pacific Smart inhalers Market Value, 2017-2028 ($ Million)

Table 37 Asia-Pacific Smart inhalers Market Share, By Type, 2018 & 2028 (%)

Table 38 Asia-Pacific Smart inhalers Market Share, By Indication, 2018 & 2028 (%)

Table 39 Asia-Pacific Smart inhalers Market Share, By Distribution Channel, 2018 & 2028 (%)

Table 40 Asia-Pacific Smart inhalers Market Share, By Country, 2018 & 2028 (%)

Table 41 Middle East & Africa Smart inhalers Market Value, 2017-2028 ($ Million)

Table 42 Middle East & Africa Smart inhalers Market Share, By Type, 2018 & 2028 (%)

Table 43 the Middle East & Africa Smart inhalers Market Share, By Indication, 2018 & 2028 (%)

Table 44 the Middle East & Africa Smart inhalers Market Share, By Distribution Channel, 2018 & 2028 (%)

Table 45 Merck: Financials

Table 46 Novartis: Financials

Table 47 Vectura Group: Financials

Table 48 MannKind: Financials

Table 49 Respirices: Financials

Table 50 Orion Pharm: Financials

Table 51 Hovione: Financials

Table 52 AstraZeneca: Financials

Table 53 OPKO Health Inc: Financials

Table 54 Boehringer-Ingelheim: Financials

Table 55 3M: Financials

Table 56 Teva: Financials

Table 57 Sunovion Pharmaceuticals: Financials

Table 58 Aristopharma: Financials

Table 59 GlaxoSmithKline: Financials

Table 60 Cohero Health LLC: Financials

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report

20% Discount Applied*



Year-End Offer from
DataM Intelligence

Note*: For "Bundle/Bulk" Subscription of Reports,
please contact: [email protected]

Get your free sample proposal with a single click!

linkedinpinterest